Hologic reports Q2 adjusted EPS $1.06, consensus 88c

Reports Q2 revenue $1.03B, consensus $958.79M. "Hologic posted robust financial results in our second fiscal quarter, with both revenue and earnings exceeding our prior guidance," said Steve MacMillan, the Company’s chairman, president and chief executive officer. "Each of our core franchises grew double digits in the period, with consolidated organic growth of more than 20%, excluding the impact of COVID. Our Breast Health and Surgical businesses delivered exceptional performance, both growing over 23% – or over 25% in constant currency, and our Diagnostics business again delivered strong results. We are also pleased to increase our full-year guidance once again."